One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025, according to one of Wall Street's major investment banks.
Innovation in genome science, big data and"ammortality," which includes wearable technology and products in the so-called wellness space, will soon prolong healthy human life well beyond 100 years, BofA told clients Wednesday. Extending human life to new bounds — long the domain of science fiction novels— could increasingly be a compelling way to make money in the public markets. With a market size already at $110 billion, the Bank of America team highlighted five key sub-themes, as well as several stocks that offer exposure to the trend.
Illumina in particular plays"an important role in helping advance disease research, drug development, and the creation of molecular tests," Tran and Israel wrote.The growth of artificial intelligence combined with an ever-growing body of health-care data should help researchers analyze pathology, or the study of the causes and effects of diseases, in the years to come.
Sounds great but, most people can't afford this.
I doubt it
Finance Finance Latest News, Finance Finance Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: WSJ - 🏆 98. / 63 Read more »